Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,009,847
-
Share change
-
+1,347,175
-
Total reported value
-
$194,609,270
-
Price per share
-
$14.03
-
Number of holders
-
72
-
Value change
-
+$14,846,816
-
Number of buys
-
50
-
Number of sells
-
26
Institutional Holders of JOUNCE THERAPEUTICS INC - COM (JNCE) as of Q2 2017
As of 30 Jun 2017,
JOUNCE THERAPEUTICS INC - COM (JNCE) was held by
72 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,009,847 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Redmile Group, LLC, Partner Fund Management, L.P., Pharmstandard International S.A., Omega Fund Management, LLC, BlackRock Inc., Cormorant Asset Management, LLC, BROWN ADVISORY INC, and VANGUARD GROUP INC.
This page lists
72
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.